Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
k9AKLV8YksAbvHwA